Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue

The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal cancers in the developed world deserves more attention. The literature supports raising this subject for awareness as a growing public health iss...

Full description

Saved in:
Bibliographic Details
Published inMedical hypotheses Vol. 63; no. 4; pp. 588 - 596
Main Author Pauley, Stephen M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 2004
Subjects
Online AccessGet full text
ISSN0306-9877
1532-2777
DOI10.1016/j.mehy.2004.03.020

Cover

Abstract The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal cancers in the developed world deserves more attention. The literature supports raising this subject for awareness as a growing public health issue. Evidence now exists that indirectly links exposures to LAN to human breast and colorectal cancers in shift workers. The hypothesis begs an even larger question: has medical science overlooked the suppression of MLT by LAN as a contributor to the overall incidence of cancer? The indirect linkage of breast cancer to LAN is further supported by laboratory rat experiments by David E. Blask and colleagues. Experiments involved the implanting of human MCF-7 breast cancer cell xenografts into the groins of rats and measurements were made of cancer cell growth rates, the uptake of linoleic acid (LA), and MLT levels. One group of implanted rats were placed in light–dark (12L:12D) and a second group in light–light (12L:12L) environments. Constant light suppressed MLT, increased cancer cell growth rates, and increased LA uptake into cancer cells. The opposite was seen in the light–dark group. The proposed mechanism is the suppression of nocturnal MLT by exposure to LAN and subsequent lack of protection by MLT on cancer cell receptor sites which allows the uptake of LA which in turn enhances the growth of cancer cells. MLT is a protective, oncostatic hormone and strong antioxidant having evolved in all plants and animals over the millennia. In vertebrates, MLT is normally produced by the pineal gland during the early morning hours of darkness, even in nocturnal animals, and is suppressed by exposure to LAN. Daily entrainment of the human circadian clock is important for good human health. These studies suggest that the proper use and color of indoor and outdoor lighting is important to the health of both humans and ecosystems. Lighting fixtures should be designed to minimize interference with normal circadian rhythms in plants and animals. New discoveries on blue-light-sensitive retinal ganglion cell light receptors that control the circadian clock and how those receptors relate to today's modern high intensity discharge (HID) lamps are discussed. There is a brief discussion of circadian rhythms and light pollution. With the precautionary principle in mind, practical suggestions are offered for better indoor and outdoor lighting practices designed to safeguard human health.
AbstractList The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal cancers in the developed world deserves more attention. The literature supports raising this subject for awareness as a growing public health issue. Evidence now exists that indirectly links exposures to LAN to human breast and colorectal cancers in shift workers. The hypothesis begs an even larger question: has medical science overlooked the suppression of MLT by LAN as a contributor to the overall incidence of cancer? The indirect linkage of breast cancer to LAN is further supported by laboratory rat experiments by David E. Blask and colleagues. Experiments involved the implanting of human MCF-7 breast cancer cell xenografts into the groins of rats and measurements were made of cancer cell growth rates, the uptake of linoleic acid (LA), and MLT levels. One group of implanted rats were placed in light–dark (12L:12D) and a second group in light–light (12L:12L) environments. Constant light suppressed MLT, increased cancer cell growth rates, and increased LA uptake into cancer cells. The opposite was seen in the light–dark group. The proposed mechanism is the suppression of nocturnal MLT by exposure to LAN and subsequent lack of protection by MLT on cancer cell receptor sites which allows the uptake of LA which in turn enhances the growth of cancer cells. MLT is a protective, oncostatic hormone and strong antioxidant having evolved in all plants and animals over the millennia. In vertebrates, MLT is normally produced by the pineal gland during the early morning hours of darkness, even in nocturnal animals, and is suppressed by exposure to LAN. Daily entrainment of the human circadian clock is important for good human health. These studies suggest that the proper use and color of indoor and outdoor lighting is important to the health of both humans and ecosystems. Lighting fixtures should be designed to minimize interference with normal circadian rhythms in plants and animals. New discoveries on blue-light-sensitive retinal ganglion cell light receptors that control the circadian clock and how those receptors relate to today's modern high intensity discharge (HID) lamps are discussed. There is a brief discussion of circadian rhythms and light pollution. With the precautionary principle in mind, practical suggestions are offered for better indoor and outdoor lighting practices designed to safeguard human health.
The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal cancers in the developed world deserves more attention. The literature supports raising this subject for awareness as a growing public health issue. Evidence now exists that indirectly links exposures to LAN to human breast and colorectal cancers in shift workers. The hypothesis begs an even larger question: has medical science overlooked the suppression of MLT by LAN as a contributor to the overall incidence of cancer? The indirect linkage of breast cancer to LAN is further supported by laboratory rat experiments by David E. Blask and colleagues. Experiments involved the implanting of human MCF-7 breast cancer cell xenografts into the groins of rats and measurements were made of cancer cell growth rates, the uptake of linoleic acid (LA), and MLT levels. One group of implanted rats were placed in light-dark (12L:12D) and a second group in light-light (12L:12L) environments. Constant light suppressed MLT, increased cancer cell growth rates, and increased LA uptake into cancer cells. The opposite was seen in the light-dark group. The proposed mechanism is the suppression of nocturnal MLT by exposure to LAN and subsequent lack of protection by MLT on cancer cell receptor sites which allows the uptake of LA which in turn enhances the growth of cancer cells. MLT is a protective, oncostatic hormone and strong antioxidant having evolved in all plants and animals over the millennia. In vertebrates, MLT is normally produced by the pineal gland during the early morning hours of darkness, even in nocturnal animals, and is suppressed by exposure to LAN. Daily entrainment of the human circadian clock is important for good human health. These studies suggest that the proper use and color of indoor and outdoor lighting is important to the health of both humans and ecosystems. Lighting fixtures should be designed to minimize interference with normal circadian rhythms in plants and animals. New discoveries on blue-light-sensitive retinal ganglion cell light receptors that control the circadian clock and how those receptors relate to today's modern high intensity discharge (HID) lamps are discussed. There is a brief discussion of circadian rhythms and light pollution. With the precautionary principle in mind, practical suggestions are offered for better indoor and outdoor lighting practices designed to safeguard human health.The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal cancers in the developed world deserves more attention. The literature supports raising this subject for awareness as a growing public health issue. Evidence now exists that indirectly links exposures to LAN to human breast and colorectal cancers in shift workers. The hypothesis begs an even larger question: has medical science overlooked the suppression of MLT by LAN as a contributor to the overall incidence of cancer? The indirect linkage of breast cancer to LAN is further supported by laboratory rat experiments by David E. Blask and colleagues. Experiments involved the implanting of human MCF-7 breast cancer cell xenografts into the groins of rats and measurements were made of cancer cell growth rates, the uptake of linoleic acid (LA), and MLT levels. One group of implanted rats were placed in light-dark (12L:12D) and a second group in light-light (12L:12L) environments. Constant light suppressed MLT, increased cancer cell growth rates, and increased LA uptake into cancer cells. The opposite was seen in the light-dark group. The proposed mechanism is the suppression of nocturnal MLT by exposure to LAN and subsequent lack of protection by MLT on cancer cell receptor sites which allows the uptake of LA which in turn enhances the growth of cancer cells. MLT is a protective, oncostatic hormone and strong antioxidant having evolved in all plants and animals over the millennia. In vertebrates, MLT is normally produced by the pineal gland during the early morning hours of darkness, even in nocturnal animals, and is suppressed by exposure to LAN. Daily entrainment of the human circadian clock is important for good human health. These studies suggest that the proper use and color of indoor and outdoor lighting is important to the health of both humans and ecosystems. Lighting fixtures should be designed to minimize interference with normal circadian rhythms in plants and animals. New discoveries on blue-light-sensitive retinal ganglion cell light receptors that control the circadian clock and how those receptors relate to today's modern high intensity discharge (HID) lamps are discussed. There is a brief discussion of circadian rhythms and light pollution. With the precautionary principle in mind, practical suggestions are offered for better indoor and outdoor lighting practices designed to safeguard human health.
The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal cancers in the developed world deserves more attention. The literature supports raising this subject for awareness as a growing public health issue. Evidence now exists that indirectly links exposures to LAN to human breast and colorectal cancers in shift workers. The hypothesis begs an even larger question: has medical science overlooked the suppression of MLT by LAN as a contributor to the overall incidence of cancer? The indirect linkage of breast cancer to LAN is further supported by laboratory rat experiments by David E. Blask and colleagues. Experiments involved the implanting of human MCF-7 breast cancer cell xenografts into the groins of rats and measurements were made of cancer cell growth rates, the uptake of linoleic acid (LA), and MLT levels. One group of implanted rats were placed in light-dark (12L:12D) and a second group in light-light (12L:12L) environments. Constant light suppressed MLT, increased cancer cell growth rates, and increased LA uptake into cancer cells. The opposite was seen in the light-dark group. The proposed mechanism is the suppression of nocturnal MLT by exposure to LAN and subsequent lack of protection by MLT on cancer cell receptor sites which allows the uptake of LA which in turn enhances the growth of cancer cells. MLT is a protective, oncostatic hormone and strong antioxidant having evolved in all plants and animals over the millennia. In vertebrates, MLT is normally produced by the pineal gland during the early morning hours of darkness, even in nocturnal animals, and is suppressed by exposure to LAN. Daily entrainment of the human circadian clock is important for good human health. These studies suggest that the proper use and color of indoor and outdoor lighting is important to the health of both humans and ecosystems. Lighting fixtures should be designed to minimize interference with normal circadian rhythms in plants and animals. New discoveries on blue-light-sensitive retinal ganglion cell light receptors that control the circadian clock and how those receptors relate to today's modern high intensity discharge (HID) lamps are discussed. There is a brief discussion of circadian rhythms and light pollution. With the precautionary principle in mind, practical suggestions are offered for better indoor and outdoor lighting practices designed to safeguard human health.
Author Pauley, Stephen M.
Author_xml – sequence: 1
  givenname: Stephen M.
  surname: Pauley
  fullname: Pauley, Stephen M.
  email: spauley@cox-internet.com
  organization: P.O. Box 3759, Ketchum, ID 83340, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15325001$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAURa2qqJ0WfoAF8opdwnOcxJmKDapaQBqJDawtx35pPHWcwXaQ5u9xNC2LLsrqWfI9d3HPFTn3s0dC3jMoGbD2076ccDyWFUBdAi-hgjOyYQ2vikoIcU42wKEttp0Ql-Qqxj0AbGveXZDLNdQAsA057OzDmKx_oMMcaBqRjsukPNU2aGXs-nKzfryhATX6lE9EFfRIrTdWq4QxQypR91wzqkh71POEVNHD0jur6YjKpYzEuOBb8mZQLuK7p3tNft3f_bz9Vux-fP1--2VX6Bp4KpQQw1D3Va2M4EIgQ65EV_VN21RbbI1pm1qzHow2nWrMgKZvTf6uG8YF6xW_Jh9PvYcw_14wJjnZqNE55XFeomzbDrZ5ghz88BRc-gmNPAQ7qXCUzxvlQHcK6DDHGHCQ2iaV7OxTUNZJBnLVIfdy1SFXHRK4zDoyWr1A_7W_Bn0-QZjn-WMxyKgteo3GZglJmtm-jt-8wLWzPrtyj3j8H_wX2aO4ow
CitedBy_id crossref_primary_10_1016_j_dyepig_2020_108917
crossref_primary_10_1016_j_cbpc_2017_08_002
crossref_primary_10_3389_fphys_2019_00822
crossref_primary_10_1038_s41467_022_31853_9
crossref_primary_10_3390_rs13081426
crossref_primary_10_1007_s10552_005_0574_1
crossref_primary_10_1039_D2TC01060G
crossref_primary_10_1021_acsmaterialsau_1c00081
crossref_primary_10_3390_ijerph19020752
crossref_primary_10_1016_j_heliyon_2024_e26259
crossref_primary_10_1016_j_scitotenv_2016_11_118
crossref_primary_10_1080_10807039_2012_702608
crossref_primary_10_1002_adma_202103102
crossref_primary_10_1007_s41449_022_00341_7
crossref_primary_10_1177_07487304241228021
crossref_primary_10_1016_j_orgel_2021_106127
crossref_primary_10_1038_s41467_020_18115_2
crossref_primary_10_3390_molecules200713005
crossref_primary_10_1016_j_energy_2022_123635
crossref_primary_10_3390_en14030527
crossref_primary_10_1016_j_landusepol_2011_10_002
crossref_primary_10_1038_srep05307
crossref_primary_10_1098_rsos_150291
crossref_primary_10_1017_S0029665118000198
crossref_primary_10_3390_su8060547
crossref_primary_10_1002_adfm_201302013
crossref_primary_10_1039_D0TC00401D
crossref_primary_10_1016_j_buildenv_2018_11_016
crossref_primary_10_1117_1_3583640
crossref_primary_10_3390_s20226603
crossref_primary_10_3390_ijms151223448
crossref_primary_10_3390_buildings14041086
crossref_primary_10_1002_adom_201901365
crossref_primary_10_33393_gcnd_2020_1100
crossref_primary_10_1021_es048589f
crossref_primary_10_1016_j_jenvman_2019_06_128
crossref_primary_10_1016_j_scs_2018_07_018
crossref_primary_10_1016_j_sleh_2018_09_006
crossref_primary_10_1158_0008_5472_CAN_05_1945
crossref_primary_10_1016_j_tust_2018_11_022
crossref_primary_10_1177_1477153513505758
crossref_primary_10_1016_j_jobe_2024_111325
crossref_primary_10_1016_j_compenvurbsys_2008_09_006
crossref_primary_10_1016_j_orgel_2016_04_002
crossref_primary_10_1039_C7RA12753G
crossref_primary_10_1007_s00432_020_03292_w
crossref_primary_10_1007_s12273_018_0433_0
crossref_primary_10_1016_j_exer_2013_01_001
crossref_primary_10_1215_00382876_8916032
crossref_primary_10_1002_advs_202411364
crossref_primary_10_3390_buildings12020161
crossref_primary_10_1039_C5RA05362E
crossref_primary_10_1038_s41598_019_43864_6
crossref_primary_10_1080_07420528_2017_1356840
crossref_primary_10_1016_j_rse_2016_02_017
crossref_primary_10_1109_JLT_2014_2309955
crossref_primary_10_1016_j_buildenv_2013_01_005
crossref_primary_10_1088_1742_6596_2069_1_012169
crossref_primary_10_1016_j_egypro_2014_10_063
crossref_primary_10_1152_physiolgenomics_00028_2021
crossref_primary_10_1155_2021_3130747
crossref_primary_10_1080_07420528_2018_1475395
crossref_primary_10_4000_vertigo_18730
crossref_primary_10_1016_j_optlaseng_2020_106174
crossref_primary_10_3310_phr03110
crossref_primary_10_1016_j_jad_2011_12_036
crossref_primary_10_3928_08910162_20101216_01
crossref_primary_10_1016_j_orgel_2012_09_037
crossref_primary_10_1007_s00420_012_0828_7
crossref_primary_10_1177_0308022614564771
crossref_primary_10_1186_s12888_017_1329_8
crossref_primary_10_3390_su152115355
crossref_primary_10_2105_AJPH_2013_301694
crossref_primary_10_1371_journal_pone_0031798
crossref_primary_10_1016_j_jobe_2023_108014
crossref_primary_10_1016_j_envres_2020_109959
crossref_primary_10_1002_adom_202300902
crossref_primary_10_1001_jamanetworkopen_2024_46156
crossref_primary_10_1002_ijch_201400066
crossref_primary_10_1021_acsmaterialslett_2c01191
crossref_primary_10_1016_j_jlumin_2023_120015
crossref_primary_10_24884_1607_4181_2022_29_2_68_76
crossref_primary_10_1002_col_22539
crossref_primary_10_1016_j_materresbull_2022_112065
crossref_primary_10_3389_fnut_2015_00004
crossref_primary_10_3109_07420528_2013_861845
crossref_primary_10_1111_j_1751_1097_2005_tb00213_x
crossref_primary_10_1097_EDE_0000000000000137
crossref_primary_10_1186_s40539_015_0030_0
crossref_primary_10_1039_C6RA19553A
crossref_primary_10_1109_LPT_2014_2326854
crossref_primary_10_1371_journal_pone_0085069
crossref_primary_10_1177_193758671400700405
crossref_primary_10_1117_1_JPE_4_043598
crossref_primary_10_7717_peerj_1075
crossref_primary_10_1080_10803548_2015_1085163
crossref_primary_10_1007_s11252_006_9354_2
crossref_primary_10_1098_rspb_2019_1051
crossref_primary_10_1016_j_scs_2020_102502
crossref_primary_10_3390_jimaging5040049
crossref_primary_10_1016_j_neulet_2006_07_069
crossref_primary_10_1039_c3tc30818a
crossref_primary_10_3389_fbuil_2019_00076
crossref_primary_10_1016_j_mehy_2008_01_016
crossref_primary_10_1002_adom_201400366
crossref_primary_10_1155_2011_839743
crossref_primary_10_1109_JPHOT_2018_2842124
crossref_primary_10_1039_D0TC02625E
crossref_primary_10_1016_j_optlastec_2018_11_046
crossref_primary_10_1021_acsami_3c14514
crossref_primary_10_1080_07420528_2017_1288632
crossref_primary_10_3390_cryst9020059
crossref_primary_10_1177_14771535231212683
crossref_primary_10_1177_216507991105900105
crossref_primary_10_2478_sjce_2019_0031
crossref_primary_10_1021_acsami_3c17222
crossref_primary_10_1007_s11769_019_1079_2
crossref_primary_10_1098_rstb_2014_0122
crossref_primary_10_1098_rstb_2014_0125
crossref_primary_10_1039_C4TC00915K
crossref_primary_10_1021_acsomega_3c05620
crossref_primary_10_1002_jez_2189
crossref_primary_10_1007_s43657_021_00039_6
crossref_primary_10_1002_adom_202001051
crossref_primary_10_1134_S2079057012040042
crossref_primary_10_1039_D0TC04934D
crossref_primary_10_3390_ijerph20043024
crossref_primary_10_3109_07420528_2010_531490
crossref_primary_10_3109_07420528_2015_1032413
crossref_primary_10_1016_j_buildenv_2021_108321
crossref_primary_10_2337_db12_1543
crossref_primary_10_1016_j_jenvp_2018_06_006
crossref_primary_10_1021_acs_chemmater_9b04739
crossref_primary_10_1021_acs_inorgchem_3c01405
crossref_primary_10_1088_1757_899X_215_1_012022
crossref_primary_10_1155_2014_480829
crossref_primary_10_1007_s13273_019_0025_9
crossref_primary_10_1016_j_healthplace_2015_05_011
crossref_primary_10_18261_tfb_7_2_2
crossref_primary_10_3109_07420520903223984
crossref_primary_10_1016_j_molstruc_2024_139568
crossref_primary_10_1016_j_tsf_2016_03_055
crossref_primary_10_3390_molecules26247558
crossref_primary_10_1016_j_jphotobiol_2020_112099
crossref_primary_10_1088_1361_6528_aa82d7
crossref_primary_10_1002_adfm_201203209
crossref_primary_10_1177_1534735415618787
crossref_primary_10_1002_j_2637_496X_2015_tb00857_x
crossref_primary_10_1038_mp_2013_70
crossref_primary_10_1117_1_OE_59_1_015104
crossref_primary_10_1007_s10517_007_0441_z
crossref_primary_10_1093_sleep_zsac145
crossref_primary_10_1080_01431160600981525
crossref_primary_10_1002_sdtp_10047
crossref_primary_10_1016_j_buildenv_2023_110616
crossref_primary_10_3390_su12020681
crossref_primary_10_1016_j_solener_2020_03_104
crossref_primary_10_1188_06_CJON_465_471
crossref_primary_10_1038_lsa_2014_22
crossref_primary_10_1002_jtr_1987
crossref_primary_10_1021_ph400007w
crossref_primary_10_1007_s12596_022_00874_4
crossref_primary_10_1016_j_buildenv_2022_109939
crossref_primary_10_1016_j_jenvman_2010_02_002
crossref_primary_10_3390_rs6086844
crossref_primary_10_3390_antiox10020210
crossref_primary_10_3390_ani13142335
crossref_primary_10_1016_j_jqsrt_2019_106644
crossref_primary_10_1080_07420528_2016_1259241
crossref_primary_10_1111_j_1444_0938_2005_tb06697_x
crossref_primary_10_1016_j_rineng_2024_102119
crossref_primary_10_1177_1477153520923379
crossref_primary_10_1007_s11356_023_29462_0
crossref_primary_10_3390_app14219798
crossref_primary_10_3390_su11113070
crossref_primary_10_1134_S207905701303003X
crossref_primary_10_37093_ijsi_932805
crossref_primary_10_1016_j_buildenv_2016_09_033
crossref_primary_10_1016_j_ijleo_2019_163994
crossref_primary_10_14324_111_444_ucloe_000036
crossref_primary_10_1038_eye_2015_221
crossref_primary_10_1080_13813455_2020_1770799
crossref_primary_10_1016_j_buildenv_2023_111052
crossref_primary_10_1038_s41578_023_00596_4
crossref_primary_10_1109_JPHOT_2015_2458989
crossref_primary_10_1039_c1jm12339d
crossref_primary_10_1007_s10517_008_0121_7
crossref_primary_10_1016_j_orgel_2016_09_005
crossref_primary_10_1177_1477153508094059
crossref_primary_10_1039_c3pp50206f
crossref_primary_10_30785_mbud_1038768
crossref_primary_10_1562_2004_12_02_IR_391_1
crossref_primary_10_1016_j_resconrec_2016_10_013
crossref_primary_10_1080_10630732_2014_884383
crossref_primary_10_1111_j_1600_079X_2007_00473_x
crossref_primary_10_1071_HE14045
crossref_primary_10_1080_17508975_2018_1543179
crossref_primary_10_1016_j_buildenv_2024_111645
crossref_primary_10_1016_j_renene_2014_06_008
crossref_primary_10_1016_j_semcdb_2017_06_011
crossref_primary_10_3390_photonics9100726
crossref_primary_10_1364_AO_51_008423
crossref_primary_10_1002_aoc_4563
crossref_primary_10_1016_j_optmat_2017_11_028
crossref_primary_10_1007_s10695_017_0408_6
crossref_primary_10_1039_D1TC03454E
crossref_primary_10_1364_OE_24_024401
crossref_primary_10_1016_j_solener_2019_07_096
crossref_primary_10_1039_C6TC01968D
crossref_primary_10_3390_su151612231
crossref_primary_10_1016_j_cbpa_2017_05_003
crossref_primary_10_1016_j_arr_2012_04_003
crossref_primary_10_1016_j_socscimed_2020_112820
crossref_primary_10_1002_sdtp_12828
crossref_primary_10_1039_c2jm16078a
crossref_primary_10_1039_D1CE01620B
crossref_primary_10_1080_15421406_2019_1596106
crossref_primary_10_1016_j_ecolind_2014_10_028
crossref_primary_10_1080_15230406_2014_987695
crossref_primary_10_1289_ehp_8987
crossref_primary_10_1039_C6TC04402F
crossref_primary_10_1039_C7TC02829F
crossref_primary_10_1364_OE_531989
crossref_primary_10_1177_1534735416660194
crossref_primary_10_1002_sdtp_10193
crossref_primary_10_1111_j_1468_4004_2010_51623_x
crossref_primary_10_1016_j_jclepro_2014_05_010
crossref_primary_10_30773_pi_2020_0348
crossref_primary_10_3109_07420528_2011_593278
crossref_primary_10_1109_JPHOT_2014_2319102
crossref_primary_10_3390_buildings15060932
crossref_primary_10_1016_j_energy_2020_119557
crossref_primary_10_1016_j_jenvman_2011_06_029
crossref_primary_10_1016_j_buildenv_2018_09_029
crossref_primary_10_1080_07420528_2017_1361436
crossref_primary_10_1002_adom_202202061
crossref_primary_10_1093_icb_icab156
crossref_primary_10_3346_jkms_2018_33_e257
crossref_primary_10_1039_C8QM00060C
crossref_primary_10_1126_sciadv_1600377
crossref_primary_10_1088_1755_1315_863_1_012015
crossref_primary_10_1016_j_orgel_2012_03_035
crossref_primary_10_3390_electronics12092099
crossref_primary_10_1177_14771535231225362
crossref_primary_10_12968_joan_2012_1_6_299
crossref_primary_10_1177_14771535221136096
crossref_primary_10_3390_rs15051209
crossref_primary_10_1063_1_4906924
crossref_primary_10_1111_j_1600_079X_2011_00934_x
crossref_primary_10_1080_07420520801921572
crossref_primary_10_1364_OE_23_00A576
crossref_primary_10_1038_srep11325
crossref_primary_10_1155_2019_3476490
crossref_primary_10_1039_C9TC05603C
crossref_primary_10_1016_j_orgel_2011_12_021
crossref_primary_10_3389_fpsyg_2023_1102761
Cites_doi 10.1054/bjoc.2000.1617
10.1210/jc.86.1.433
10.1038/sj.bjc.6601626
10.1006/frne.1999.0194
10.1016/0006-8993(82)90931-3
10.1016/S0940-2993(00)80022-6
10.1023/A:1024030518065
10.1097/00001648-200101000-00013
10.1016/S0024-3205(01)01062-1
10.1034/j.1600-079X.2002.01881.x
10.1097/00001648-199809000-00004
10.1016/S1357-2725(01)00059-0
10.1023/A:1008897317401
10.1093/jnci/93.20.1513
10.1093/jnci/93.20.1563
10.1126/science.1067262
10.1016/S0166-2236(03)00130-9
10.1055/s-2002-28352
10.1097/00001648-199105000-00008
10.1016/S1521-690X(03)00016-2
10.1093/carcin/18.8.1549
10.1054/mehy.1999.0810
10.1159/000226857
10.1177/074873049701200608
10.1038/nature01761
10.1126/science.7434030
10.1016/S0006-3223(98)00357-6
10.1111/j.1753-4887.2001.tb07018.x
10.1002/(SICI)1099-1263(200001/02)20:1<21::AID-JAT623>3.0.CO;2-M
10.1093/jnci/95.11.825
10.1023/A:1011237000609
10.1016/0165-1781(91)90016-I
10.1016/S0959-8049(05)80087-5
10.1016/0006-8993(88)90820-7
10.1016/0006-8993(84)91045-X
10.1523/JNEUROSCI.21-16-06405.2001
10.1309/1T4V-CT1G-UBJP-3EHP
10.1126/science.1077293
10.1159/000014545
10.1007/BF01291882
10.1210/jc.2003-030570
10.2174/1568026023394407
10.1007/978-1-4615-4709-9_48
10.1016/0031-9384(93)90024-A
10.1093/jnci/93.20.1557
10.1038/sj.bjc.6690544
10.1016/S0006-2952(01)00634-7
10.1056/NEJM200010123431510
ContentType Journal Article
Copyright 2004 Elsevier Ltd
Copyright 2004 Elsevier Ltd.
Copyright_xml – notice: 2004 Elsevier Ltd
– notice: Copyright 2004 Elsevier Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.mehy.2004.03.020
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1532-2777
EndPage 596
ExternalDocumentID 15325001
10_1016_j_mehy_2004_03_020
S0306987704002336
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29M
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAWTL
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABGSF
ABJNI
ABLJU
ABMAC
ABMZM
ABUDA
ABWVN
ABXDB
ABZDS
ACDAQ
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADUVX
AEBSH
AEHWI
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HZ~
IHE
J1W
KOM
LZ2
M29
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSP
SSU
SSZ
T5K
UHS
WUQ
Z5R
ZGI
~G-
AACTN
AAIAV
AATCM
ABLVK
ABYKQ
AFCTW
AFKWA
AJBFU
AJOXV
AMFUW
DOVZS
EFLBG
LCYCR
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c403t-a77ff4b24ad7377e1e3a782b56529e6dd654c1b0dcd8a5dfedb6d2b5451371ba3
IEDL.DBID .~1
ISSN 0306-9877
IngestDate Fri Sep 05 07:30:27 EDT 2025
Wed Feb 19 01:53:28 EST 2025
Thu Apr 24 23:10:41 EDT 2025
Tue Jul 01 00:51:53 EDT 2025
Fri Feb 23 02:29:14 EST 2024
Tue Aug 26 16:33:50 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright 2004 Elsevier Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c403t-a77ff4b24ad7377e1e3a782b56529e6dd654c1b0dcd8a5dfedb6d2b5451371ba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15325001
PQID 66809001
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_66809001
pubmed_primary_15325001
crossref_citationtrail_10_1016_j_mehy_2004_03_020
crossref_primary_10_1016_j_mehy_2004_03_020
elsevier_sciencedirect_doi_10_1016_j_mehy_2004_03_020
elsevier_clinicalkey_doi_10_1016_j_mehy_2004_03_020
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004
2004-1-00
2004-00-00
20040101
PublicationDateYYYYMMDD 2004-01-01
PublicationDate_xml – year: 2004
  text: 2004
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Medical hypotheses
PublicationTitleAlternate Med Hypotheses
PublicationYear 2004
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
References Veitch JA. Principles of healthy lighting. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Carlin S. The precautionary principle. Available from
Schernhammer, Laden, Speizer, Willett, Hunter, Kawachi (BIB70) 2001; 93
Brainard, Richardson, Petterborg, Reiter (BIB15) 1982; 233
Reiter RJ. Melatonin bantam books; 1995
Hattar, Lucas, Mrosovsky, Thopson, Douglas, Hankins (BIB42) 2003; 424
Schernhammer, Schulmeister (BIB69) 2004; 90
Arendt (BIB5) 2000; 343
Blask DE, Wilson ST, Cos S, Lemus-Wilson AM, Liaw L. Pineal and circadian influence on the inhibitory growth response of experimental breast cancer to melatonin. In: Proceedings of the 74th Annual Meeting of Endocrinology Society; 1992. p. 376
Anisimov, Popovich, Zabezhinski (BIB2) 1997; 18
Anisimov, Hansen (BIB1) 2002; 23
Hahn (BIB39) 1991; 2
Web site for Devra Davs PhD
Brainard, Richardson, King, Reiter (BIB21) 1984; 294
Figueiro M, Eggleston G, Rea MS. Effects of light exposure on behavior of Alzheimer's patients-a pilot study. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Wiley, Formby (BIB79) 2000
Stewart, Gaddy, Byrne, Miller, Brainard (BIB76) 1991; 38
Anisimov, Popovich, Shtylik, Zabezinski, Fen-Huh, Gurevich (BIB3) 2000; 52
Blask, Dauchy, Sauer, Krause, Brainard (BIB9) 2003; 79
Nathan, Burrows, Norman (BIB52) 1997; 104
Stevens, Rae (BIB74) 2001; 12
Berson, Dunn, Motoharu (BIB7) 2002; 295
Sauer, Dauchy, Blask (BIB65) 2001; 68
Davis, Mirick, Stevens (BIB27) 2001; 93
Miller N. Lighting for seniors: obstacles in applying the research. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Brainard, Hanifin, Greeson, Byrne, Glickman, Gerner (BIB19) 2001; 21
Montague P. The precautionary principle Rachel's environment and health weekly #586 February 19; 1998. Available from
Lewy, Wehr, Goodwin (BIB47) 1980; 210
Rea, Bullough, Figueiro (BIB59) 2002; 32
Brainard (BIB20) 1978
Feychting, Osterlund, Ahlbom (BIB35) 1998; 9
Blask, Sauer, Dauchy (BIB13) 2002; 2
Cos, Sanchez-Barcelo (BIB25) 2000; 21
Erren, Piekarski (BIB31) 1999; 53
Sauer, Dauchy, Blask, Armstrong, Scalici (BIB68) 1999; 59
Kliukiene, Tynes, Andersen (BIB46) 2001; 84
Noell-Waggoner E. Let there be light, or face the consequences: a national concern for our aging population. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Lockley, Brainard, Czeisler (BIB48) 2003; 88
Rea MS. Light-much more than vision. keynote address. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Dillon, Easley, Asch, Cheney, Brydon, Jockers (BIB28) 2002; 118
Quera-Salva, Defrance, Claustrat, De Lattre, Guilleminault (BIB56) 1996; 19
Reiter, Tan, Cabrera, D'Arpa (BIB63) 1999; 467
Cos, Sanchez-Barcelo (BIB26) 2000; 15
>
Hansen (BIB41) 2001; 12
Appell (BIB4) 2001
Lucas, Hattar, Takao, Berson, Foster, Yau (BIB49) 2003
Glickman, Levin, Brainard (BIB38) 2002
Reiter (BIB61) 2003; 17
Sauer, Dauchy, Blask (BIB66) 2001; 61
Schernhammer, Laden, Speizer, Willett, Hunter, Kawachi (BIB71) 2003; 95
Erren, Stevens (BIB32) 2002; 64
Karbownik, Lewinski, Reiter (BIB45) 2001; 33
Coleman, Reiter (BIB24) 1992; 28
Falkson, Falkson, Steyn, Rapoport, Meyer (BIB33) 1990; 47
Erren (BIB30) 2002; 23
Ferriol, Venereo, Orta, Castellanos, Segovia-Selvestre (BIB34) 2000; 20
Pang, Pang, Poon, Lee, Liu, Shiu (BIB54) 1998; 111
Blask, Sauer, Dauchy, Holowachuk, Ruhoff, Kopff (BIB10) 1999; 59
Fontoynont M. Simulation of sunlight in indoor environments. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Roberts JE. Light interactions with the human eye as a function of age. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Stevens RG. Epidemiological evidence on artificial lighting patterns and risk of breast cancer. Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Bubenik, Blask, Brown, Maestroni, Pang, Reiter (BIB22) 1998; 7
Verkasalo, Pukkala, Stevens, Ojamo, Rudanko (BIB78) 1999; 80
Dollins, Lynch, Wurtman, Deng, Lieberman (BIB29) 1993; 53
Pukkala, Verkasalo, Ojamo, Rudanko (BIB55) 1999; 10
Sauer, Dauchy, Blask (BIB67) 2000; 60
Berson (BIB6) 2003; 26
Brainard GC. Photoreception for regulation of melatonin and the circadian system in humans. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Hansen (BIB40) 2001; 93
Reiter, Tan, Burkhardt, Manchester (BIB62) 2001; 59
Hatonen, Alila-Johansson, Mustanoja, Laakso (BIB43) 1999; 46
Blask, Dauchy, Sauer, Krause, Brainard (BIB11) 2002; 23
Brainard, Lewy, Menaker, Fredrickson, Miller, Weleber (BIB18) 1988; 454
Schulmeister K, Weber M, Bogner W, Schernhammer E. Application of melatonin action spectra on practical lighting issues. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Brainard, Hanifin, Rollag, Greeson, Byrne, Glickman (BIB16) 2001; 86
Berson DM. Melanopsin and phototransduction by retinal ganglion cells. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Ramstad, Loge (BIB57) 2002; 122
Brainard, Rollag, Hanifin (BIB17) 1997; 12
Stevens (BIB73) 2002; 23
Holick MF, Vitamin D: a required supplement or a sunshine hormone? In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
Cos (10.1016/j.mehy.2004.03.020_BIB26) 2000; 15
Ramstad (10.1016/j.mehy.2004.03.020_BIB57) 2002; 122
Pang (10.1016/j.mehy.2004.03.020_BIB54) 1998; 111
Sauer (10.1016/j.mehy.2004.03.020_BIB67) 2000; 60
10.1016/j.mehy.2004.03.020_BIB44
Glickman (10.1016/j.mehy.2004.03.020_BIB38) 2002
Erren (10.1016/j.mehy.2004.03.020_BIB32) 2002; 64
Hansen (10.1016/j.mehy.2004.03.020_BIB40) 2001; 93
Reiter (10.1016/j.mehy.2004.03.020_BIB63) 1999; 467
Bubenik (10.1016/j.mehy.2004.03.020_BIB22) 1998; 7
10.1016/j.mehy.2004.03.020_BIB8
Blask (10.1016/j.mehy.2004.03.020_BIB10) 1999; 59
Rea (10.1016/j.mehy.2004.03.020_BIB59) 2002; 32
Berson (10.1016/j.mehy.2004.03.020_BIB6) 2003; 26
Lockley (10.1016/j.mehy.2004.03.020_BIB48) 2003; 88
Hahn (10.1016/j.mehy.2004.03.020_BIB39) 1991; 2
Quera-Salva (10.1016/j.mehy.2004.03.020_BIB56) 1996; 19
10.1016/j.mehy.2004.03.020_BIB72
Stewart (10.1016/j.mehy.2004.03.020_BIB76) 1991; 38
Feychting (10.1016/j.mehy.2004.03.020_BIB35) 1998; 9
10.1016/j.mehy.2004.03.020_BIB77
Lucas (10.1016/j.mehy.2004.03.020_BIB49) 2003
Sauer (10.1016/j.mehy.2004.03.020_BIB66) 2001; 61
10.1016/j.mehy.2004.03.020_BIB75
10.1016/j.mehy.2004.03.020_BIB37
10.1016/j.mehy.2004.03.020_BIB36
Davis (10.1016/j.mehy.2004.03.020_BIB27) 2001; 93
Dollins (10.1016/j.mehy.2004.03.020_BIB29) 1993; 53
Erren (10.1016/j.mehy.2004.03.020_BIB30) 2002; 23
Erren (10.1016/j.mehy.2004.03.020_BIB31) 1999; 53
Schernhammer (10.1016/j.mehy.2004.03.020_BIB71) 2003; 95
Reiter (10.1016/j.mehy.2004.03.020_BIB61) 2003; 17
Reiter (10.1016/j.mehy.2004.03.020_BIB62) 2001; 59
Brainard (10.1016/j.mehy.2004.03.020_BIB15) 1982; 233
Brainard (10.1016/j.mehy.2004.03.020_BIB16) 2001; 86
Sauer (10.1016/j.mehy.2004.03.020_BIB68) 1999; 59
Cos (10.1016/j.mehy.2004.03.020_BIB25) 2000; 21
10.1016/j.mehy.2004.03.020_BIB60
10.1016/j.mehy.2004.03.020_BIB23
Sauer (10.1016/j.mehy.2004.03.020_BIB65) 2001; 68
10.1016/j.mehy.2004.03.020_BIB64
Blask (10.1016/j.mehy.2004.03.020_BIB9) 2003; 79
Blask (10.1016/j.mehy.2004.03.020_BIB11) 2002; 23
Brainard (10.1016/j.mehy.2004.03.020_BIB18) 1988; 454
Anisimov (10.1016/j.mehy.2004.03.020_BIB2) 1997; 18
Verkasalo (10.1016/j.mehy.2004.03.020_BIB78) 1999; 80
Coleman (10.1016/j.mehy.2004.03.020_BIB24) 1992; 28
Ferriol (10.1016/j.mehy.2004.03.020_BIB34) 2000; 20
Wiley (10.1016/j.mehy.2004.03.020_BIB79) 2000
Brainard (10.1016/j.mehy.2004.03.020_BIB20) 1978
Arendt (10.1016/j.mehy.2004.03.020_BIB5) 2000; 343
Brainard (10.1016/j.mehy.2004.03.020_BIB21) 1984; 294
10.1016/j.mehy.2004.03.020_BIB51
10.1016/j.mehy.2004.03.020_BIB50
10.1016/j.mehy.2004.03.020_BIB12
Falkson (10.1016/j.mehy.2004.03.020_BIB33) 1990; 47
Berson (10.1016/j.mehy.2004.03.020_BIB7) 2002; 295
Dillon (10.1016/j.mehy.2004.03.020_BIB28) 2002; 118
Hattar (10.1016/j.mehy.2004.03.020_BIB42) 2003; 424
Hatonen (10.1016/j.mehy.2004.03.020_BIB43) 1999; 46
10.1016/j.mehy.2004.03.020_BIB53
10.1016/j.mehy.2004.03.020_BIB14
Nathan (10.1016/j.mehy.2004.03.020_BIB52) 1997; 104
10.1016/j.mehy.2004.03.020_BIB58
Blask (10.1016/j.mehy.2004.03.020_BIB13) 2002; 2
Pukkala (10.1016/j.mehy.2004.03.020_BIB55) 1999; 10
Brainard (10.1016/j.mehy.2004.03.020_BIB19) 2001; 21
Kliukiene (10.1016/j.mehy.2004.03.020_BIB46) 2001; 84
Brainard (10.1016/j.mehy.2004.03.020_BIB17) 1997; 12
Schernhammer (10.1016/j.mehy.2004.03.020_BIB69) 2004; 90
Karbownik (10.1016/j.mehy.2004.03.020_BIB45) 2001; 33
Schernhammer (10.1016/j.mehy.2004.03.020_BIB70) 2001; 93
Stevens (10.1016/j.mehy.2004.03.020_BIB73) 2002; 23
Anisimov (10.1016/j.mehy.2004.03.020_BIB3) 2000; 52
Appell (10.1016/j.mehy.2004.03.020_BIB4) 2001
Lewy (10.1016/j.mehy.2004.03.020_BIB47) 1980; 210
Hansen (10.1016/j.mehy.2004.03.020_BIB41) 2001; 12
Anisimov (10.1016/j.mehy.2004.03.020_BIB1) 2002; 23
Stevens (10.1016/j.mehy.2004.03.020_BIB74) 2001; 12
References_xml – volume: 59
  start-page: 4688
  year: 1999
  end-page: 4692
  ident: BIB68
  article-title: 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid- dependent growth in rat hepatoma 7288CTC in vivo
  publication-title: Cancer Res.
– volume: 9
  start-page: 490
  year: 1998
  end-page: 494
  ident: BIB35
  article-title: Reduced cancer incidence among the blind
  publication-title: Epidemiology
– volume: 28
  start-page: 501
  year: 1992
  end-page: 503
  ident: BIB24
  article-title: Breast cancer, blindness and melatonin
  publication-title: Eur. J. Cancer
– volume: 12
  start-page: 279
  year: 2001
  end-page: 287
  ident: BIB74
  article-title: Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer
  publication-title: Cancer Cause. Control
– volume: 295
  start-page: 1070
  year: 2002
  end-page: 1073
  ident: BIB7
  article-title: Phototransduction by retinal ganglion cells that set the circadian clock
  publication-title: Science
– volume: 23
  start-page: 52
  year: 2002
  end-page: 56
  ident: BIB11
  article-title: Light during darkness, melatonin suppression and cancer progression
  publication-title: Neuroendocrinol. Lett.
– reference: Montague P. The precautionary principle Rachel's environment and health weekly #586 February 19; 1998. Available from: <
– reference: Berson DM. Melanopsin and phototransduction by retinal ganglion cells. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 47
  start-page: 401
  year: 1990
  end-page: 405
  ident: BIB33
  article-title: Plasma melatonin in patients with breast cancer
  publication-title: Oncology
– reference: Holick MF, Vitamin D: a required supplement or a sunshine hormone? In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– reference: Rea MS. Light-much more than vision. keynote address. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 21
  start-page: 133
  year: 2000
  end-page: 170
  ident: BIB25
  article-title: Melatonin and mammary pathological growth
  publication-title: Front. Neuroendocrinol.
– reference: Fontoynont M. Simulation of sunlight in indoor environments. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– reference: Veitch JA. Principles of healthy lighting. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 32
  start-page: 209
  year: 2002
  end-page: 213
  ident: BIB59
  article-title: Phototransduction for human melatonin suppression
  publication-title: J. Pineal Res.
– volume: 17
  start-page: 273
  year: 2003
  end-page: 285
  ident: BIB61
  article-title: Melatonin: clinical relevance
  publication-title: Best Pract. Res. Clin. Endocrinol. Metab.
– reference: >. Web site for Devra Davs PhD
– volume: 18
  start-page: 1549
  year: 1997
  end-page: 1553
  ident: BIB2
  article-title: Melatonin and colon carcinogenesis. I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats
  publication-title: Carcinogenesis
– volume: 88
  start-page: 4502
  year: 2003
  end-page: 4505
  ident: BIB48
  article-title: High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 21
  start-page: 6405
  year: 2001
  end-page: 6412
  ident: BIB19
  article-title: Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor
  publication-title: J. Neurosci.
– reference: Carlin S. The precautionary principle. Available from: <
– volume: 64
  start-page: 278
  year: 2002
  end-page: 283
  ident: BIB32
  article-title: Light, melatonin and internal cancers – recent facts and research perspectives
  publication-title: Gesundheitswesen
– volume: 79
  start-page: 313
  year: 2003
  end-page: 320
  ident: BIB9
  article-title: Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression
  publication-title: Breast Cancer Res. Tr.
– volume: 80
  start-page: 1459
  year: 1999
  end-page: 1460
  ident: BIB78
  article-title: Inverse association between breast cancer incidence and degree of visual impairment in Finland
  publication-title: Br. J. Cancer
– reference: Stevens RG. Epidemiological evidence on artificial lighting patterns and risk of breast cancer. Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 23
  start-page: 84
  year: 2002
  end-page: 87
  ident: BIB1
  article-title: Light, endocrine systems and cancer – a meeting report
  publication-title: Neuroendocrinol. Lett.
– volume: 454
  start-page: 212
  year: 1988
  end-page: 218
  ident: BIB18
  article-title: Dose–response relationship between light irradiance and the suppression of plasma melatonin in human volunteers
  publication-title: Brain Res.
– volume: 46
  start-page: 827
  year: 1999
  end-page: 831
  ident: BIB43
  article-title: Suppresson of melatonin by 2000-lx light in humans with closed eyes
  publication-title: Biol. Psychiat.
– volume: 93
  start-page: 1557
  year: 2001
  end-page: 1562
  ident: BIB27
  article-title: Night-shift work, light at night, and risk of breast cancer
  publication-title: J. Natl. Cancer Inst.
– volume: 2
  start-page: 113
  year: 2002
  end-page: 132
  ident: BIB13
  article-title: Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy
  publication-title: Curr. Top. Med. Chem.
– volume: 233
  start-page: 75
  year: 1982
  end-page: 81
  ident: BIB15
  article-title: The effect of different light intensities on pineal melatonin content
  publication-title: Brain Res.
– year: 2000
  ident: BIB79
  article-title: Lights out; sleep, sugar, and survival
– volume: 90
  start-page: 941
  year: 2004
  end-page: 943
  ident: BIB69
  article-title: Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?
  publication-title: Brit. J. Cancer
– volume: 23
  start-page: 57
  year: 2002
  end-page: 60
  ident: BIB73
  article-title: Lighting during the day and night: possible impact on risk of breast cancer
  publication-title: Neuroendocrinol. Lett.
– volume: 93
  start-page: 1563
  year: 2001
  end-page: 1568
  ident: BIB70
  article-title: Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study
  publication-title: J. Natl. Cancer Inst.
– volume: 52
  start-page: 71
  year: 2000
  end-page: 76
  ident: BIB3
  article-title: Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats
  publication-title: Exp. Toxicol. Pathol.
– volume: 26
  start-page: 314
  year: 2003
  end-page: 320
  ident: BIB6
  article-title: Strange vision: ganglion cells as circadian photoreceptors
  publication-title: Trends Neurosci.
– volume: 294
  start-page: 333
  year: 1984
  end-page: 339
  ident: BIB21
  article-title: The influence of different light spectra on the suppression of pineal melatonin content in the Syrian hamster
  publication-title: Brain Res.
– volume: 111
  start-page: 197
  year: 1998
  end-page: 203
  ident: BIB54
  article-title: Melatonin: a chemical photoperiodic signal with clinical significance in humans
  publication-title: Chin. Med. J. (Engl.)
– reference: Noell-Waggoner E. Let there be light, or face the consequences: a national concern for our aging population. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 59
  start-page: 4693
  year: 1999
  end-page: 4701
  ident: BIB10
  article-title: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events
  publication-title: Cancer Res.
– volume: 424
  start-page: 75
  year: 2003
  end-page: 81
  ident: BIB42
  article-title: Melanopsin and rod-cone photoreceptive systems account for all accessory major visual functions in mice
  publication-title: Nature
– reference: Blask DE, Wilson ST, Cos S, Lemus-Wilson AM, Liaw L. Pineal and circadian influence on the inhibitory growth response of experimental breast cancer to melatonin. In: Proceedings of the 74th Annual Meeting of Endocrinology Society; 1992. p. 376
– reference: Figueiro M, Eggleston G, Rea MS. Effects of light exposure on behavior of Alzheimer's patients-a pilot study. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– start-page: 245
  year: 2003
  end-page: 247
  ident: BIB49
  article-title: Diminished pupillary light reflex at high irradiances in melanopsin knock out mice
  publication-title: Science
– volume: 93
  start-page: 1513
  year: 2001
  end-page: 1515
  ident: BIB40
  article-title: Light at night, shiftwork, and breast cancer risk
  publication-title: J. Natl, Cancer Inst.
– volume: 19
  start-page: 539
  year: 1996
  end-page: 543
  ident: BIB56
  article-title: Rapid shift in sleep time and acrophase of melatonin secretion in short shift work schedule
  publication-title: Sleep
– reference: Brainard GC. Photoreception for regulation of melatonin and the circadian system in humans. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 20
  start-page: 21
  year: 2000
  end-page: 24
  ident: BIB34
  article-title: In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line
  publication-title: J. Appl. Toxicol.
– volume: 343
  start-page: 1114
  year: 2000
  end-page: 1116
  ident: BIB5
  article-title: Melatonin, circadian rhythms, and sleep
  publication-title: New Engl. J. Med.
– volume: 53
  start-page: 153
  year: 1993
  end-page: 160
  ident: BIB29
  article-title: Effects of illumination on human nocturnal serum melatonin levels and performance
  publication-title: Physiol. Behav.
– volume: 86
  start-page: 433
  year: 2001
  end-page: 436
  ident: BIB16
  article-title: Human melatonin regulation is not mediated by the three cone photopic visual system
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 33
  start-page: 735
  year: 2001
  end-page: 753
  ident: BIB45
  article-title: Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants
  publication-title: Int. J. Biochem. Cell. Biol.
– start-page: 3
  year: 1978
  end-page: 10
  ident: BIB20
  article-title: Pineal research: the decade of transformation
  publication-title: J. Neural Transm.-Suppl.
– volume: 210
  start-page: 1267
  year: 1980
  end-page: 1269
  ident: BIB47
  article-title: Light suppresses melatonin secretions in humans
  publication-title: Science
– reference: Miller N. Lighting for seniors: obstacles in applying the research. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– reference: Reiter RJ. Melatonin bantam books; 1995
– volume: 60
  start-page: 5289
  year: 2000
  end-page: 9567
  ident: BIB67
  article-title: Mechanism for the antitumor and anticachetic effects of
  publication-title: Cancer Res.
– volume: 84
  start-page: 397
  year: 2001
  end-page: 399
  ident: BIB46
  article-title: Risk of breast cancer among Norwegian women with visual impairment
  publication-title: Br. J. Cancer
– volume: 59
  start-page: 286
  year: 2001
  end-page: 290
  ident: BIB62
  article-title: Melatonin in plants
  publication-title: Nutr. Rev.
– volume: 68
  start-page: 2835
  year: 2001
  end-page: 2844
  ident: BIB65
  article-title: Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction
  publication-title: Life Sci.
– volume: 61
  start-page: 1455
  year: 2001
  end-page: 1462
  ident: BIB66
  article-title: Polyunsaturated fatty acids, melatonin, and cancer prevention
  publication-title: Biochem. Pharmacol.
– volume: 95
  start-page: 825
  year: 2003
  end-page: 828
  ident: BIB71
  article-title: Night-shift work and risk of colorectal cancer in the Nurses' Health Study
  publication-title: J. Natl. Cancer Inst.
– volume: 467
  start-page: 379
  year: 1999
  end-page: 387
  ident: BIB63
  article-title: Melatonin and tryptophan derivatives as free radical scavengers and antioxidants
  publication-title: Adv. Exp. Med. Biol.
– reference: Schulmeister K, Weber M, Bogner W, Schernhammer E. Application of melatonin action spectra on practical lighting issues. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– volume: 122
  start-page: 1005
  year: 2002
  end-page: 1006
  ident: BIB57
  article-title: Melatonin treatment of a blind child with serious sleep disorders
  publication-title: Tidsskr Nor Laegeforen
– volume: 104
  start-page: 643
  year: 1997
  end-page: 648
  ident: BIB52
  article-title: The effect of dim light on suppression of nocturnal melatonin in healthy women and men
  publication-title: J. Neural. Transm.
– volume: 12
  start-page: 74
  year: 2001
  end-page: 77
  ident: BIB41
  article-title: Increased breast cancer risk among women who work predominately at night
  publication-title: Epidemiology
– reference: Roberts JE. Light interactions with the human eye as a function of age. In: Final Report. The Fifth International LRO Lighting Research Symposium, Light and Human Health, November 3–5, 2002. Report No. 1009370. Palo Alto, CA: The Electric Power Research Institute; 2004
– year: 2001
  ident: BIB4
  article-title: The new uncertainty principle
– volume: 23
  start-page: 61
  year: 2002
  end-page: 70
  ident: BIB30
  article-title: Does light cause internal cancers? The problem and challenge of an ubiquitous exposure
  publication-title: Neuroendocrinol. Lett.
– volume: 2
  start-page: 208
  year: 1991
  end-page: 210
  ident: BIB39
  article-title: Profound bilateral blindness and the incidence of breast cancer
  publication-title: Epidemiology
– volume: 118
  start-page: 451
  year: 2002
  end-page: 458
  ident: BIB28
  article-title: Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue
  publication-title: Am. J. Clin. Pathol.
– volume: 12
  start-page: 537
  year: 1997
  end-page: 546
  ident: BIB17
  article-title: Photic regulation of melatonin in humans: ocular and neural signal transduction
  publication-title: J. Biol. Rhythm.
– volume: 53
  start-page: 1
  year: 1999
  end-page: 5
  ident: BIB31
  article-title: Does winter darkness in the Artic protect against cancer? The melatonin hypothesis revisited
  publication-title: Med. Hypotheses
– volume: 7
  start-page: 195
  year: 1998
  end-page: 219
  ident: BIB22
  article-title: Prospects of the clinical utilization of melatonin
  publication-title: Biol. Signal. Recept.
– start-page: 17
  year: 2002
  end-page: 22
  ident: BIB38
  article-title: Ocular input for human melatonin regulation: relevance to breast cancer
  publication-title: Neuroendocrinol. Lett.
– reference: >
– volume: 38
  start-page: 261
  year: 1991
  end-page: 270
  ident: BIB76
  article-title: Effects of green or white light for treatment of seasonal depression
  publication-title: Psychiat. Res.
– volume: 15
  start-page: 637
  year: 2000
  end-page: 647
  ident: BIB26
  article-title: Melatonin, experimental basis for a possible application in breast cancer prevention and treatment
  publication-title: Histol. Histopathol.
– volume: 10
  start-page: 13
  year: 1999
  end-page: 20
  ident: BIB55
  article-title: Visual impairment and cancer: a population-based cohort study in Finland
  publication-title: Cancer Cause. Control
– volume: 59
  start-page: 4688
  issue: 18
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB68
  article-title: 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid- dependent growth in rat hepatoma 7288CTC in vivo
  publication-title: Cancer Res.
– volume: 84
  start-page: 397
  issue: 3
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB46
  article-title: Risk of breast cancer among Norwegian women with visual impairment
  publication-title: Br. J. Cancer
  doi: 10.1054/bjoc.2000.1617
– ident: 10.1016/j.mehy.2004.03.020_BIB37
– volume: 86
  start-page: 433
  issue: 1
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB16
  article-title: Human melatonin regulation is not mediated by the three cone photopic visual system
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.86.1.433
– volume: 90
  start-page: 941
  issue: 5
  year: 2004
  ident: 10.1016/j.mehy.2004.03.020_BIB69
  article-title: Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels?
  publication-title: Brit. J. Cancer
  doi: 10.1038/sj.bjc.6601626
– year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB79
– volume: 21
  start-page: 133
  issue: 2
  year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB25
  article-title: Melatonin and mammary pathological growth
  publication-title: Front. Neuroendocrinol.
  doi: 10.1006/frne.1999.0194
– volume: 122
  start-page: 1005
  issue: 10
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB57
  article-title: Melatonin treatment of a blind child with serious sleep disorders
  publication-title: Tidsskr Nor Laegeforen
– ident: 10.1016/j.mehy.2004.03.020_BIB14
– volume: 15
  start-page: 637
  issue: 2
  year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB26
  article-title: Melatonin, experimental basis for a possible application in breast cancer prevention and treatment
  publication-title: Histol. Histopathol.
– volume: 233
  start-page: 75
  issue: 1
  year: 1982
  ident: 10.1016/j.mehy.2004.03.020_BIB15
  article-title: The effect of different light intensities on pineal melatonin content
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(82)90931-3
– volume: 52
  start-page: 71
  year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB3
  article-title: Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats
  publication-title: Exp. Toxicol. Pathol.
  doi: 10.1016/S0940-2993(00)80022-6
– volume: 79
  start-page: 313
  issue: 3
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB9
  article-title: Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression
  publication-title: Breast Cancer Res. Tr.
  doi: 10.1023/A:1024030518065
– volume: 12
  start-page: 74
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB41
  article-title: Increased breast cancer risk among women who work predominately at night
  publication-title: Epidemiology
  doi: 10.1097/00001648-200101000-00013
– volume: 68
  start-page: 2835
  issue: 25
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB65
  article-title: Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction
  publication-title: Life Sci.
  doi: 10.1016/S0024-3205(01)01062-1
– volume: 111
  start-page: 197
  issue: 3
  year: 1998
  ident: 10.1016/j.mehy.2004.03.020_BIB54
  article-title: Melatonin: a chemical photoperiodic signal with clinical significance in humans
  publication-title: Chin. Med. J. (Engl.)
– volume: 32
  start-page: 209
  issue: 4
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB59
  article-title: Phototransduction for human melatonin suppression
  publication-title: J. Pineal Res.
  doi: 10.1034/j.1600-079X.2002.01881.x
– volume: 9
  start-page: 490
  issue: 5
  year: 1998
  ident: 10.1016/j.mehy.2004.03.020_BIB35
  article-title: Reduced cancer incidence among the blind
  publication-title: Epidemiology
  doi: 10.1097/00001648-199809000-00004
– volume: 33
  start-page: 735
  issue: 8
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB45
  article-title: Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants
  publication-title: Int. J. Biochem. Cell. Biol.
  doi: 10.1016/S1357-2725(01)00059-0
– volume: 10
  start-page: 13
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB55
  article-title: Visual impairment and cancer: a population-based cohort study in Finland
  publication-title: Cancer Cause. Control
  doi: 10.1023/A:1008897317401
– volume: 93
  start-page: 1513
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB40
  article-title: Light at night, shiftwork, and breast cancer risk
  publication-title: J. Natl, Cancer Inst.
  doi: 10.1093/jnci/93.20.1513
– volume: 93
  start-page: 1563
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB70
  article-title: Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/93.20.1563
– volume: 295
  start-page: 1070
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB7
  article-title: Phototransduction by retinal ganglion cells that set the circadian clock
  publication-title: Science
  doi: 10.1126/science.1067262
– volume: 26
  start-page: 314
  issue: 6
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB6
  article-title: Strange vision: ganglion cells as circadian photoreceptors
  publication-title: Trends Neurosci.
  doi: 10.1016/S0166-2236(03)00130-9
– volume: 64
  start-page: 278
  issue: 5
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB32
  article-title: Light, melatonin and internal cancers – recent facts and research perspectives
  publication-title: Gesundheitswesen
  doi: 10.1055/s-2002-28352
– volume: 2
  start-page: 208
  year: 1991
  ident: 10.1016/j.mehy.2004.03.020_BIB39
  article-title: Profound bilateral blindness and the incidence of breast cancer
  publication-title: Epidemiology
  doi: 10.1097/00001648-199105000-00008
– volume: 17
  start-page: 273
  issue: 2
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB61
  article-title: Melatonin: clinical relevance
  publication-title: Best Pract. Res. Clin. Endocrinol. Metab.
  doi: 10.1016/S1521-690X(03)00016-2
– volume: 18
  start-page: 1549
  year: 1997
  ident: 10.1016/j.mehy.2004.03.020_BIB2
  article-title: Melatonin and colon carcinogenesis. I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/18.8.1549
– volume: 53
  start-page: 1
  issue: 1
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB31
  article-title: Does winter darkness in the Artic protect against cancer? The melatonin hypothesis revisited
  publication-title: Med. Hypotheses
  doi: 10.1054/mehy.1999.0810
– ident: 10.1016/j.mehy.2004.03.020_BIB23
– volume: 47
  start-page: 401
  issue: 5
  year: 1990
  ident: 10.1016/j.mehy.2004.03.020_BIB33
  article-title: Plasma melatonin in patients with breast cancer
  publication-title: Oncology
  doi: 10.1159/000226857
– ident: 10.1016/j.mehy.2004.03.020_BIB50
– ident: 10.1016/j.mehy.2004.03.020_BIB75
– ident: 10.1016/j.mehy.2004.03.020_BIB44
– ident: 10.1016/j.mehy.2004.03.020_BIB72
  doi: 10.1038/sj.bjc.6601626
– volume: 12
  start-page: 537
  issue: 6
  year: 1997
  ident: 10.1016/j.mehy.2004.03.020_BIB17
  article-title: Photic regulation of melatonin in humans: ocular and neural signal transduction
  publication-title: J. Biol. Rhythm.
  doi: 10.1177/074873049701200608
– year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB4
– volume: 424
  start-page: 75
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB42
  article-title: Melanopsin and rod-cone photoreceptive systems account for all accessory major visual functions in mice
  publication-title: Nature
  doi: 10.1038/nature01761
– volume: 210
  start-page: 1267
  year: 1980
  ident: 10.1016/j.mehy.2004.03.020_BIB47
  article-title: Light suppresses melatonin secretions in humans
  publication-title: Science
  doi: 10.1126/science.7434030
– ident: 10.1016/j.mehy.2004.03.020_BIB60
– volume: 59
  start-page: 4693
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB10
  article-title: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events
  publication-title: Cancer Res.
– ident: 10.1016/j.mehy.2004.03.020_BIB12
– volume: 46
  start-page: 827
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB43
  article-title: Suppresson of melatonin by 2000-lx light in humans with closed eyes
  publication-title: Biol. Psychiat.
  doi: 10.1016/S0006-3223(98)00357-6
– ident: 10.1016/j.mehy.2004.03.020_BIB58
– ident: 10.1016/j.mehy.2004.03.020_BIB64
– volume: 59
  start-page: 286
  issue: 9
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB62
  article-title: Melatonin in plants
  publication-title: Nutr. Rev.
  doi: 10.1111/j.1753-4887.2001.tb07018.x
– volume: 20
  start-page: 21
  year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB34
  article-title: In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line
  publication-title: J. Appl. Toxicol.
  doi: 10.1002/(SICI)1099-1263(200001/02)20:1<21::AID-JAT623>3.0.CO;2-M
– ident: 10.1016/j.mehy.2004.03.020_BIB8
  doi: 10.1126/science.1067262
– volume: 23
  start-page: 57
  issue: Suppl 2
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB73
  article-title: Lighting during the day and night: possible impact on risk of breast cancer
  publication-title: Neuroendocrinol. Lett.
– volume: 95
  start-page: 825
  issue: 11
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB71
  article-title: Night-shift work and risk of colorectal cancer in the Nurses' Health Study
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/95.11.825
– volume: 12
  start-page: 279
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB74
  article-title: Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer
  publication-title: Cancer Cause. Control
  doi: 10.1023/A:1011237000609
– volume: 38
  start-page: 261
  issue: 3
  year: 1991
  ident: 10.1016/j.mehy.2004.03.020_BIB76
  article-title: Effects of green or white light for treatment of seasonal depression
  publication-title: Psychiat. Res.
  doi: 10.1016/0165-1781(91)90016-I
– ident: 10.1016/j.mehy.2004.03.020_BIB51
– volume: 28
  start-page: 501
  issue: 2–3
  year: 1992
  ident: 10.1016/j.mehy.2004.03.020_BIB24
  article-title: Breast cancer, blindness and melatonin
  publication-title: Eur. J. Cancer
  doi: 10.1016/S0959-8049(05)80087-5
– start-page: 3
  issue: 13
  year: 1978
  ident: 10.1016/j.mehy.2004.03.020_BIB20
  article-title: Pineal research: the decade of transformation
  publication-title: J. Neural Transm.-Suppl.
– volume: 23
  start-page: 52
  issue: Suppl 2
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB11
  article-title: Light during darkness, melatonin suppression and cancer progression
  publication-title: Neuroendocrinol. Lett.
– start-page: 17
  issue: Suppl 2
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB38
  article-title: Ocular input for human melatonin regulation: relevance to breast cancer
  publication-title: Neuroendocrinol. Lett.
– volume: 454
  start-page: 212
  issue: 1–2
  year: 1988
  ident: 10.1016/j.mehy.2004.03.020_BIB18
  article-title: Dose–response relationship between light irradiance and the suppression of plasma melatonin in human volunteers
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(88)90820-7
– volume: 23
  start-page: 84
  issue: Suppl 2
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB1
  article-title: Light, endocrine systems and cancer – a meeting report
  publication-title: Neuroendocrinol. Lett.
– ident: 10.1016/j.mehy.2004.03.020_BIB36
– volume: 294
  start-page: 333
  issue: 2
  year: 1984
  ident: 10.1016/j.mehy.2004.03.020_BIB21
  article-title: The influence of different light spectra on the suppression of pineal melatonin content in the Syrian hamster
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(84)91045-X
– volume: 21
  start-page: 6405
  issue: 16
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB19
  article-title: Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.21-16-06405.2001
– volume: 118
  start-page: 451
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB28
  article-title: Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue
  publication-title: Am. J. Clin. Pathol.
  doi: 10.1309/1T4V-CT1G-UBJP-3EHP
– start-page: 245
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB49
  article-title: Diminished pupillary light reflex at high irradiances in melanopsin knock out mice
  publication-title: Science
  doi: 10.1126/science.1077293
– volume: 7
  start-page: 195
  issue: 4
  year: 1998
  ident: 10.1016/j.mehy.2004.03.020_BIB22
  article-title: Prospects of the clinical utilization of melatonin
  publication-title: Biol. Signal. Recept.
  doi: 10.1159/000014545
– volume: 23
  start-page: 61
  issue: Suppl 2
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB30
  article-title: Does light cause internal cancers? The problem and challenge of an ubiquitous exposure
  publication-title: Neuroendocrinol. Lett.
– volume: 104
  start-page: 643
  issue: 6–7
  year: 1997
  ident: 10.1016/j.mehy.2004.03.020_BIB52
  article-title: The effect of dim light on suppression of nocturnal melatonin in healthy women and men
  publication-title: J. Neural. Transm.
  doi: 10.1007/BF01291882
– ident: 10.1016/j.mehy.2004.03.020_BIB53
– volume: 88
  start-page: 4502
  issue: 9
  year: 2003
  ident: 10.1016/j.mehy.2004.03.020_BIB48
  article-title: High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2003-030570
– volume: 2
  start-page: 113
  issue: 2
  year: 2002
  ident: 10.1016/j.mehy.2004.03.020_BIB13
  article-title: Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026023394407
– volume: 467
  start-page: 379
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB63
  article-title: Melatonin and tryptophan derivatives as free radical scavengers and antioxidants
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4615-4709-9_48
– volume: 60
  start-page: 5289
  year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB67
  article-title: Mechanism for the antitumor and anticachetic effects of n−3 fatty acids
  publication-title: Cancer Res.
– volume: 53
  start-page: 153
  issue: 1
  year: 1993
  ident: 10.1016/j.mehy.2004.03.020_BIB29
  article-title: Effects of illumination on human nocturnal serum melatonin levels and performance
  publication-title: Physiol. Behav.
  doi: 10.1016/0031-9384(93)90024-A
– volume: 19
  start-page: 539
  issue: 7
  year: 1996
  ident: 10.1016/j.mehy.2004.03.020_BIB56
  article-title: Rapid shift in sleep time and acrophase of melatonin secretion in short shift work schedule
  publication-title: Sleep
– volume: 93
  start-page: 1557
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB27
  article-title: Night-shift work, light at night, and risk of breast cancer
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/93.20.1557
– volume: 80
  start-page: 1459
  issue: 9
  year: 1999
  ident: 10.1016/j.mehy.2004.03.020_BIB78
  article-title: Inverse association between breast cancer incidence and degree of visual impairment in Finland
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6690544
– ident: 10.1016/j.mehy.2004.03.020_BIB77
– volume: 61
  start-page: 1455
  year: 2001
  ident: 10.1016/j.mehy.2004.03.020_BIB66
  article-title: Polyunsaturated fatty acids, melatonin, and cancer prevention
  publication-title: Biochem. Pharmacol.
  doi: 10.1016/S0006-2952(01)00634-7
– volume: 343
  start-page: 1114
  issue: 15
  year: 2000
  ident: 10.1016/j.mehy.2004.03.020_BIB5
  article-title: Melatonin, circadian rhythms, and sleep
  publication-title: New Engl. J. Med.
  doi: 10.1056/NEJM200010123431510
SSID ssj0009438
Score 2.227648
Snippet The hypothesis that the suppression of melatonin (MLT) by exposure to light at night (LAN) may be one reason for the higher rates of breast and colorectal...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 588
SubjectTerms Chronobiology Disorders - complications
Chronobiology Disorders - physiopathology
Circadian Rhythm - radiation effects
Clinical Trials as Topic
Environmental Exposure - adverse effects
Evidence-Based Medicine
Humans
Light
Lighting - adverse effects
Lighting - methods
Melatonin - metabolism
Models, Biological
Neoplasms - etiology
Neoplasms - physiopathology
Occupational Diseases - etiology
Occupational Diseases - physiopathology
Public Health - methods
Public Health - trends
Risk Assessment - methods
Risk Factors
Title Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0306987704002336
https://dx.doi.org/10.1016/j.mehy.2004.03.020
https://www.ncbi.nlm.nih.gov/pubmed/15325001
https://www.proquest.com/docview/66809001
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEF4hkFAvFc82PPfQW2ViZ8demxuKQKEtXAoSt9W-rKSFJCLhwIXfzsx6HYQEVOrV3vFjZ3bnm50XY9-sL12NpkYiewISkLTmUE0gQ6yuKufS3NN5x8VlMbiGHzf5zRLrt7kwFFYZ9_5mTw-7dbzSjbPZnY5G3d-EdtFiliSGPSGo7DaAJFk_enoJ86ggdLOmwQmNjokzTYzXnR8-BhsxFDqlnt9vK6f3wGdQQmdr7HNEj_yk-cB1tuTHG2z1IvrHN9n0F9naqI04YlGO2I6HHnzcju5tKELALSqvv8cc_xm1DY-lfoacPNcUGzVDIj3nt-1jhnrGcf4nd55r3pTE5k3qJA8c22LXZ6dX_UESeyokFlIxT7SUdQ2mB9pJIaXPvNAIEgziul7lC-eKHGxmUmddqXNXe2cKh7chz4TMjBbbbHk8GfuvjGeyFD51ugaPVpkAQz7AUqQGTAUVmA7L2slUNhYcp74Xt6qNLPujiAHUCRNUKhQyoMO-L2imTbmND0eLlkeqTSTFrU-hNviQKl9QvRK1f9IdtmKgcA2SY0WP_eRhpoqiTCvU9x32pZGOl2_PBWLMNNv5z3fusk9NqBCd-eyx5fn9g99HFDQ3B0HMD9jKyfnPweUzHR0Fow
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB5BKgEX1Ja2pC_2wA25sbNrr82tQqC0TbgUJG6rfVkJhSQiyYELv70z6zUICajUq73jx87szjc7L4B960tXo6mRyD4XiZC05lBNIEOsrirn0tzTecfotBici58X-cUaHLW5MBRWGff-Zk8Pu3W80ouz2ZtPJr3fhHbRYpYkhn3Oi3V4JXIuKa7v291DnEclQjtrGp3Q8Jg50wR5XfvxbTASQ6VTavr9tHZ6Dn0GLXTyGrYjfGTfmy98A2t--hY2RtFBvgPzIRnbqI4YglGG4I6FJnzMTm5sqELALGqvP4cMfxrVDYu1fsaMXNcUHLVAIr1kV-1jxnrBkAGza880a2pisyZ3kgWWvYPzk-Ozo0ESmyokVqR8mWgp61qYvtBOcil95rlGlGAQ2PUrXzhX5MJmJnXWlTp3tXemcHhb5BmXmdH8PXSms6nfBZbJkvvU6Vp4NMu4MOQELHlqhKlEJUwXsnYylY0Vx6nxxZVqQ8suFTGAWmEKlXKFDOjCwT3NvKm38eJo3vJItZmkuPcpVAcvUuX3VI9k7Z90e60YKFyE5FnRUz9bLVRRlGmFCr8LHxrpePj2nCPITLOP__nOPdgcnI2Gavjj9Ncn2GrihugA6DN0ljcr_wUh0dJ8DSL_FxCVBzY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lighting+for+the+human+circadian+clock%3A+recent+research+indicates+that+lighting+has+become+a+public+health+issue&rft.jtitle=Medical+hypotheses&rft.au=Pauley%2C+Stephen+M.&rft.date=2004&rft.pub=Elsevier+Ltd&rft.issn=0306-9877&rft.volume=63&rft.issue=4&rft.spage=588&rft.epage=596&rft_id=info:doi/10.1016%2Fj.mehy.2004.03.020&rft.externalDocID=S0306987704002336
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-9877&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-9877&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-9877&client=summon